Massive Bio, Inc.
Massive Bio is an AI-powered precision medicine platform that connects cancer patients to clinical trials worldwide, aiming to improve access to innovative treatments. The company operates globally, partnering with pharmaceutical companies and healthcare systems to advance drug development and ensure equitable access to therapies.
Massive Bio is a healthcare technology company that uses AI-driven cancer analysis and clinical trial matching to connect oncology patients with appropriate investigational therapies. Their platform integrates clinical and genomic data to identify and prioritize trial matches, streamline referrals, and simplify enrollment workflows for hospitals, cancer centers, and life‑science sponsors. The company also offers patient navigation, molecular tumor board support, and site activation services to improve the patient experience and boost trial accrual. Massive Bio works with health systems, biopharma, and CRO partners to accelerate precision oncology research and broaden access to clinical trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Massive Bio, Inc..
28% above the average for this role
Software Developer
Signant Health
Pharmaceutical Technician
Catalent
Solutions Architecture, GTM Strategy Director/Senior Director
N-Power Medicine
Medical Doctors for Pharmaceutical Medicine Programme
State of Indiana
Medical Director, Early Clinical Development, Oncology
American Association of Physicists in Medicine
Director, Clinical Pharmacology
Cogent Biosciences